Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 19 studies | 29% ± 13% | |
| pericyte | 11 studies | 28% ± 11% | |
| connective tissue cell | 7 studies | 36% ± 18% | |
| smooth muscle cell | 7 studies | 19% ± 3% | |
| myofibroblast cell | 4 studies | 33% ± 13% | |
| basal cell | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 4 studies | 28% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 100% | 6483.39 | 1809 / 1809 | 96% | 67.99 | 455 / 472 |
| breast | 100% | 2305.34 | 459 / 459 | 92% | 25.19 | 1023 / 1118 |
| uterus | 99% | 3414.20 | 169 / 170 | 84% | 43.34 | 385 / 459 |
| bladder | 100% | 3798.10 | 21 / 21 | 75% | 32.40 | 378 / 504 |
| esophagus | 92% | 1023.49 | 1331 / 1445 | 73% | 49.16 | 134 / 183 |
| lung | 89% | 1076.13 | 516 / 578 | 76% | 30.48 | 876 / 1155 |
| prostate | 99% | 1999.56 | 243 / 245 | 64% | 11.80 | 323 / 502 |
| ovary | 99% | 1821.34 | 178 / 180 | 55% | 10.64 | 235 / 430 |
| pancreas | 59% | 360.84 | 195 / 328 | 87% | 29.97 | 155 / 178 |
| adrenal gland | 93% | 793.00 | 241 / 258 | 50% | 11.58 | 114 / 230 |
| kidney | 87% | 908.82 | 77 / 89 | 47% | 8.46 | 426 / 901 |
| intestine | 88% | 931.42 | 848 / 966 | 46% | 7.57 | 242 / 527 |
| stomach | 75% | 657.52 | 271 / 359 | 57% | 8.87 | 164 / 286 |
| thymus | 91% | 950.20 | 591 / 653 | 42% | 8.12 | 254 / 605 |
| eye | 0% | 0 | 0 / 0 | 100% | 66.99 | 80 / 80 |
| adipose | 100% | 2305.72 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 45.03 | 44 / 45 |
| blood vessel | 97% | 1415.70 | 1297 / 1335 | 0% | 0 | 0 / 0 |
| liver | 46% | 273.33 | 103 / 226 | 50% | 10.48 | 201 / 406 |
| spleen | 95% | 1340.61 | 228 / 241 | 0% | 0 | 0 / 0 |
| heart | 76% | 734.88 | 658 / 861 | 0% | 0 | 0 / 0 |
| brain | 13% | 77.35 | 336 / 2642 | 29% | 5.34 | 203 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 3.48 | 9 / 29 |
| muscle | 22% | 137.73 | 174 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006325 | Biological process | chromatin organization |
| GO_0007605 | Biological process | sensory perception of sound |
| GO_1902034 | Biological process | negative regulation of hematopoietic stem cell proliferation |
| GO_0001837 | Biological process | epithelial to mesenchymal transition |
| GO_0003198 | Biological process | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO_0007219 | Biological process | Notch signaling pathway |
| GO_0033028 | Biological process | myeloid cell apoptotic process |
| GO_0045667 | Biological process | regulation of osteoblast differentiation |
| GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
| GO_0006933 | Biological process | negative regulation of cell adhesion involved in substrate-bound cell migration |
| GO_0001649 | Biological process | osteoblast differentiation |
| GO_0003180 | Biological process | aortic valve morphogenesis |
| GO_2000811 | Biological process | negative regulation of anoikis |
| GO_0060693 | Biological process | regulation of branching involved in salivary gland morphogenesis |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0033629 | Biological process | negative regulation of cell adhesion mediated by integrin |
| GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
| GO_0071425 | Biological process | hematopoietic stem cell proliferation |
| GO_0033033 | Biological process | negative regulation of myeloid cell apoptotic process |
| GO_0014032 | Biological process | neural crest cell development |
| GO_0003273 | Biological process | cell migration involved in endocardial cushion formation |
| GO_0060536 | Biological process | cartilage morphogenesis |
| GO_0010839 | Biological process | negative regulation of keratinocyte proliferation |
| GO_0032331 | Biological process | negative regulation of chondrocyte differentiation |
| GO_0060021 | Biological process | roof of mouth development |
| GO_0030335 | Biological process | positive regulation of cell migration |
| GO_0070563 | Biological process | negative regulation of vitamin D receptor signaling pathway |
| GO_0043542 | Biological process | endothelial cell migration |
| GO_2000810 | Biological process | regulation of bicellular tight junction assembly |
| GO_0043473 | Biological process | pigmentation |
| GO_0045600 | Biological process | positive regulation of fat cell differentiation |
| GO_1902230 | Biological process | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_2001240 | Biological process | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO_0071479 | Biological process | cellular response to ionizing radiation |
| GO_0060429 | Biological process | epithelium development |
| GO_0010957 | Biological process | negative regulation of vitamin D biosynthetic process |
| GO_0043518 | Biological process | negative regulation of DNA damage response, signal transduction by p53 class mediator |
| GO_0035921 | Biological process | desmosome disassembly |
| GO_0050872 | Biological process | white fat cell differentiation |
| GO_0032642 | Biological process | regulation of chemokine production |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| GO_0003682 | Molecular function | chromatin binding |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0070888 | Molecular function | E-box binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SNAI2 |
| Protein name | Zinc finger protein SNAI2 (Neural crest transcription factor Slug) (Protein snail homolog 2) Snail family transcriptional repressor 2 |
| Synonyms | SLUG SLUGH |
| Description | FUNCTION: Transcriptional repressor that modulates both activator-dependent and basal transcription. Involved in the generation and migration of neural crest cells. Plays a role in mediating RAF1-induced transcriptional repression of the TJ protein, occludin (OCLN) and subsequent oncogenic transformation of epithelial cells (By similarity). Represses BRCA2 expression by binding to its E2-box-containing silencer and recruiting CTBP1 and HDAC1 in breast cells. In epidermal keratinocytes, binds to the E-box in ITGA3 promoter and represses its transcription. Involved in the regulation of ITGB1 and ITGB4 expression and cell adhesion and proliferation in epidermal keratinocytes. Binds to E-box2 domain of BSG and activates its expression during TGFB1-induced epithelial-mesenchymal transition (EMT) in hepatocytes. Represses E-Cadherin/CDH1 transcription via E-box elements. Involved in osteoblast maturation. Binds to RUNX2 and SOC9 promoters and may act as a positive and negative transcription regulator, respectively, in osteoblasts. Binds to CXCL12 promoter via E-box regions in mesenchymal stem cells and osteoblasts. Plays an essential role in TWIST1-induced EMT and its ability to promote invasion and metastasis. . |
| Accessions | ENST00000020945.4 A0A1X7SC17 ENST00000396822.6 O43623 |